Techne Corp.
614 McKinley Place NE
Minneapolis,
MN 55413-2610
Phone: 612-379-8854
Fax: 612-379-6580
Web Site: http://www.techne-corp.com
| TECHNE Corporation and its subsidiaries engage in the development, manufacture, and sale of biotechnology products, and hematology calibrators and controls primarily in the United States and Europe. The companys biotechnology product line includes Cytokines, extracted from natural sources or produced using recombinant DNA technology; Enzymes and related factors, including enzyme substrates and inhibitors; antibodies, proteins produced by the immune system of an animal; assay kits, such as human and animal Quantikine kits, which allow research scientists to quantify the amount of a specific analyte; clinical diagnostic kits, including erythropoietin, transferrin receptor, and Beta2-microglobulin immunoassays; flow cytometry products consisting of fluorochrome labeled antibodies and Fluorokine kits, which measure the presence or absence of cell surface receptors for specific cytokines by flow cytometry; and intracellular cell signaling products, including antibodies, phospho-specific antibodies, antibody protein arrays, active caspases, kinases, phosphatases, and ELISA assays. Its hematology product line comprises whole blood CBC controls/calibrators; linearity and reportable range controls that provide a means of assessing the linearity of hematology analyzers for white blood cells, red blood cells, platelets, and reticulocytes; whole blood reticulocyte controls for manual and automated counting of reticulocytes; whole blood flow cytometry controls for flow cytometry instruments; whole blood glucose/hemoglobin control to monitor instruments which measure glucose and hemoglobin in whole blood; erythrocyte sedimentation rate control to monitor erythrocyte sedimentation rate tests; and multi-purpose platelet reference controls for use by automated and semi-automated analyzers. TECHNE Corporation sells its products to research and clinical diagnostics markets. The company was founded in 1976 and is headquartered in Minneapolis, Minnesota. |
|
| Key Statistics |
|
|
|
| |
Pay |
Exercised |
Mr. Thomas E. Oland , 68
Chairman, Chief Exec. Officer, Pres and Treasurer
|
$
254.00K |
$
0 |
Mr. Gregory J. Melsen , 56
Chief Financial Officer and VP of Fin.
|
$
287.00K |
$
0 |
Mr. Marcel Veronneau , 55
VP of Hematology Operations
|
$
198.00K |
$
27.00K |
Kathleen M. Backes ,
Chief Accounting Officer and Controller
|
N/A
|
N/A |
|
|
|
Dollar amounts are as of
31-Dec-09
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
|
|
|
Help
0.08 (0.12%) 
Profile
